Importance Neonatal abstinence syndrome, which occurs as a result of in utero opioid
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …

Objectives: The prevalence of opioid use disorder (OUD) during pregnancy is increasing.
Practical recommendations will help providers treat pregnant women with OUD and reduce …

METHODS: In early 2013, a multidisciplinary quality improvement team began consecutive
plan-do-study-act (PDSA) cycles. We trained nurses in modified Finnegan scoring, ensured …

Discussion| This study found that all commonly prescribed antibiotics during infancy are
associated with subsequent diagnosis of allergic disease. Administration of more than 1 …

METHODS: From 2012 to 2014, data were collected through serial cross-sectional audits of
participating centers. Hospitals assessed institutional policies and patient-level data for …

OBJECTIVES: To reduce average length of stay (ALOS) in infants with neonatal abstinence
syndrome (NAS) transferred to the inpatient floor from the mother-infant unit. Secondarily, we …

Neonatal abstinence syndrome (NAS) is a drug withdrawal syndrome that most commonly
occurs in infants after in utero exposure to opioids, although other substances have also …

Pain management in the neonatal ICU remains challenging for many clinicians and in many
complex care circumstances. The authors review general pain management principles and …

Women who use substances in pregnancy are an underserved population with a higher risk
for maternal morbidity and neonatal morbidity and mortality. Maternal substance use affects …

NAS remains a critical public health issue associated with significant medical, economic,
and personal burdens. Emerging data on associated risk factors, assessment of and …